Consolidated financial statements (Thousands Baht) Six-month Change 2nd Quarter Change 2020 2019 Amount % 2020 2019 Amount % Revenue from sales 1,165,249 1,068,077 97,172 9.10% 538,525 512,616 25,909 5.05% Other

by the preparation of the consolidated financial statements. 3. Reversal of provisions for litigation The decrease from the same period last year by 10.88 million baht due to Q2 2016 Reversal of

statement for the year period ended December 31, 2019, details are as follows: The operating results of the consolidated financial statement for the year period ended December 31, 2019 The Consolidated

7.01 40.54% Consolidated financial information The gross profit increased Baht 11.83 million or 20.58%; from Baht 57.49 million in quarter 1/2017 to Baht 69.31 million in quarter 1/2018, due to following

คำอธิบายและการวิเคราะห์ฐานะการเงินและผลการดำเนินงาน * Note Please find further information in the consolidated financial statements. 1 February 21st, 2020 Subject: Management Discussion & Analysis

* Note Please find further information in the consolidated financial statements. 1 23 February, 2018 Subject: Management Discussion & Analysis (MD&A) for the year 2017 Attention: The President The

as related to Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd that would impact on the consolidated financial statements and the separate financial statements. Therefore, the SEC has notified EE (1

* Note Please find further information in the consolidated financial statements. 1 9th May, 2018 Subject: Management Discussion & Analysis (MD&A) for the 1st quarter of 2018 Attention: The President

* Note Please find further information in the consolidated financial statements. 1 9th May, 2019 Subject: Management Discussion & Analysis (MD&A) for the 1st quarter of 2019 Attention: The President

* Note Please find further information in the consolidated financial statements. 1 8th August, 2019 Subject: Management Discussion & Analysis (MD&A) for the 2nd quarter of 2019 Attention: The